Center for Biologic Counterterrorism and Emerging Diseases

ATTENZIONE!
Il tuo browser non supporta JavaScript!
Questo impedisce il corretto funzionamento delle pagine del sito.

Torna a visitarci dopo aver installato un browser più aggiornato,
come gli ultimi Microsoft Internet Explorer o Netscape Navigator.

Assicurati inoltre di aver abilitato nelle preferenze l'uso di JavaScript.

Center for Biologic Counterterrorism
and Emerging Diseases CBC-ED

MedStar Health Group Washington, DC Cloud Updated Thursday, May 23, 2013 7:15 EST

Craig Feied, MD, FACEP, FAAEM Jon Handler, MD, FACEP Michael Gillam, MD

Switch to framed viewer

Logged in as: guest ()

Avian Influenza Bepast Newsletters
	UN and World Bank Issue Global Progress Report on Avian Flu and Pandemic Preparedness: Specific Countries and Case Studies as Examples [10/14/2008]
	Pakistan 2007: Family cluster of 5 brothers with H5N1 Avian Flu infection includes the full clinical spectrum from fatalities to the (rare) asymptomatic household contact case [10/7/2008]
	WHO reports that 107/107 (100%) of influenza A (H1N1) human viruses this flu season are resistant to oseltamivir (Tamiflu) (Note: This is not avian H5N1) [10/7/2008]
	New H5N1 virus Clade 2.3.4 (‘Fujian-like lineage’) available for vaccine development [9/14/2008]
	New H5N1 Patients in China, Vietnam, Indonesia and Thailand as Winter Nears 26 November 2006 [1/1/2006]
	Flu Color Table: Three types of Influenza Vaccines 28 November 2005 [1/1/2006]
	WHO Reference Labs developing new experimental H5N1 vaccine prototype strains 11 November 2005 [1/1/2006]
	Africa and the Threat of Avian and Pandemic Flu: The US Should Act Now October 29, 2005 [11/13/2005]
	New H5N1 infections in Avians in Romania, Russia, China, Thailand, and in birds smuggled into Taipei, China; First new human infection in Thailand in 12 months; No evidence of “P2P” or “P5P” transmission October 21, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [10/23/2005]
	Avian H5N1 Influenza Virus Confirmed in Europe Today October 13, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [10/20/2005]
	October 4-8: The 100-Hour “Tipping Point” in US Pandemic Flu Awareness October 9, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [10/11/2005]
	US to stockpile second drug (zanamivir) to treat H5N1 influenza, add $100 million worth of H5N1 vaccine, and travel to SE Asia in October September 17, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [9/30/2005]
	UN Director General appoints WHO Expert to Lead Avian Flu Efforts, New WHO paper on H5N1, and more cases in Indonesia September 29, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [9/30/2005]
	Bird Flu closes Jakarta Zoo, H5N1 human case(s) confirmed September 20, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [9/30/2005]
	WHO issues new H5N1 pandemic flu recommendations for policy makers September 14, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [9/13/2005]
	Children and H5N1: Ages, Fatalities, and Antiviral Limitations August 30, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [8/29/2005]
	“Necessary but Not Sufficient”: The 3 Million Courses of Oseltamivir for H5N1 Nascent Pandemic Control. Five (5) Other Criteria are Required, Similar to the US Cities Readiness Initiative (CRI) August 25, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [8/24/2005]
	WHO to receive 3 million treatment courses (30 million capsules) of the only oral anti-H5N1 drug (oseltamivir) by mid-2006 as outbreaks spread to Kazakhstan, Russia and Tibet24 August 24 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [8/23/2005]
	H5N1 Flu Virus Confirmed in Russia; Is Mongolia Next? August 8, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [8/8/2005]
	H5N1: Hypercytokinemia and Hemophagocytosis July 29, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [7/28/2005]
	H5N1 Lab Research at CDC: Important Science, Predictable Accusations July 23, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [7/24/2005]
	Indonesia: H5N1 now in Humans in addition to Poultry and Pigs July 22, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [7/21/2005]
	Thailand Avian Flu Newsletter June 17, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [7/3/2005]
	H5N1 Vaccines: Update June 9, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [6/8/2005]
	H5N1 Cases rise to 97 with Changing Epidemiology in 2005: WHO Director-General calls avian influenza “the most serious known health threat the world is facing today”. May 20, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [5/19/2005]
	Cities Readiness Initiative expanding to 36 Cities: Mass distribution of (effective) antibiotics May 14, 2005: Daniel R. Lucey MD, MPH Director for Biological counterterrorism and Emerging Diseases [5/13/2005]
	“Pacific Storm”: Tabletop Exercise for a Pandemic H5N1 Flu May 9, 2005: Daniel R. Lucey MD, MPH, Director for Biologic Counterterrorism and Emerging Diseases [5/8/2005]
	Oseltamivir, Influenza, and the Media April 28, 2005: Daniel R. Lucey MD, MPH, Director for Biologic Counterterrorism and Emerging Diseases [4/27/2005]
	Dangerous H2N2 influenza virus mistakenly sent for lab testing April 13, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [4/12/2005]
	H5N1 flu virus toll rises to 74 patients with 49 dead: Pandemic Prodrome? March 31, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [3/30/2005]
	Avian influenza: 88% of initial 50 cases are 1-30 years old February 14, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [2/13/2005]
	H7N7 Avian Flu in the Netherlands: High Rate of Human-to-Human transmission January 14, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [1/13/2005]
	New H5N1 Deaths in Vietnam January 11, 2005: Daniel R. Lucey MD, MPH Director for Biologic Counterterrorism and Emerging Diseases [1/10/2005]
	The US Pandemic Influenza Plan: Just in Time? August 31, 2004: Daniel R. Lucey MD, MPH, Director for Biologic Counterterrorism and Emerging Diseases [8/30/2004]

Avian Influenza Disease Information
	Priming With DNA Vaccine Makes Avian Flu Vaccine Work Better EurekNews [10/4/2011]
	Evaluation Of A Virosomal H5N1 Vaccine Formulated With Matrix M™ Adjuvant In A Phase I Clinical Trial ScienceDirect - Vaccine [8/24/2011]
	Structural And Functional Bases For Broad Spectrum [Nat Struct Mol Biol. 2009] - = PubMed result [7/26/2011]
	Influenza A (H5N1) Viruses from Pigs, Indonesia Emerg Infect Dis. 2010 Oct [8/16/2010]
	Mapping The Risk Of Avian Influenza In Wild Birds In The US BMC Abstract [6/25/2010]
	Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease March 17 2010: PLoS ONE [3/17/2010]
	Novel inhaled drug found effective against H5N1 avian influenza virus February 26 2010: Sify News [2/25/2010]
	PLoS ONE Mutations In H5N1 Influenza Virus Hemagglutinin That Confer Binding To Human Tracheal Airway Epithelium [11/18/2009]
	NEJM - Probable Person-to-Person Transmission of Avian Influenza A (H5N1) January 24, 2005: Early release article [2/11/2009]
	The evolution of H5N1 influenza viruses in ducks in southern China July 2, 2004: Proceedings of the National Academy of Sciences [2/11/2009]
	Avian Influenza H5N1 in Tigers and Leopards December 2004: CDC EID Ahead of print article [2/11/2009]
	H5N1 avian influenza: Timeline of major events (pdf) WHO - January 21 2009 [2/5/2009]
	Neutrophils May Be a Vehicle for Viral Replication and Dissemination in Human H5N1 Avian Influenza Chicago Journals - Clinical Infectious Diseases [11/10/2008]
	Incubation Period For Human Cases Of Avian Influenza A (H5N1) Infection, China CDC EID [10/29/2008]
	Responses to Avian Influenza and State of Pandemic Readiness Fourth Global Progress Report October 2008 (pdf) UN System Influenza Coordinator & The World BankProgress Report [10/15/2008]
	Cumulative Number Of Confirmed Human Cases Of Avian Influenza A (H5N1) Reported To WHO September 10, 2008 [10/5/2008]
	Single step multiplex real-time RT-PCR for H5N1 influenza A virus detection The Journal of Virological Methods [9/29/2008]
	Clinical Characteristics Of 26 Human Cases Of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection In China PLoS ONE article [8/25/2008]
	Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series The Lancet article [8/15/2008]
	NEJM: A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture June 12, 2008 article [6/11/2008]
	Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile(pdf) WHO scientific consultation [5/17/2008]
	Wild Ducks As Vectors Of HPAIV (H5N1) CDC EID document [3/27/2008]
	Antegenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines (pdf) WHO - February 2008 [2/24/2008]
	NEJM Update On Avian Influenza A (H5N1) Virus Infection In Humans [1/16/2008]
	WHO H5N1 Clinical Case Summary Form (pdf) [1/4/2008]
	WHO Clinical Management Human Avian Influenza (pdf) August, 2007 [1/4/2008]
	Clinical management of human infection with avian influenza A (H5N1) virus (pdf) This WHO document came out on August 15, 2007. [8/22/2007]
	DoD: Pandemic Influenza: Clinical and Public Health Guidelines for the Military Health System (pdf) [5/9/2007]
	DoD Implementation Plan for Pandemic Influenza(pdf) August 2006 [5/9/2007]
	Pandemic Mitigation PandemicFlu.gov [2/1/2007]
	CDC EID - Risk Factors for Human Infection with Avian Influenza A H5N1, Vietnam, 2004 [12/2/2006]
	OSHA Guidance For Protecting Employees Against Avian Flu [11/17/2006]
	WHO: Avian influenza: food safety issues http://www.who.int/foodsafety/micro/avian/en/ [3/8/2006]
	WHO: Avian influenza: significance of mutations in the H5N1 virus February 2006 [3/5/2006]
	Flu Color Table November 2005 [1/1/2006]
	CIDRAP: H5N1 Avian Flu Viruses What's In A Name December 2005 [1/1/2006]
	WHO Guidance On Public Health Measures In Countries Experiencing Their First Outbreaks Of H5N1 Avian Influenza October 2005 [10/30/2005]

[This site developed and operated by Craig Feied MD, Jon Handler MD, and Mike Gillam MD]